Dr. Reddy’s Laboratories announced the launch of Moxifloxacin HCl Tablets, the generic version of Bayer HealthCare’s Avelox.

Avelox is a quinolone antibiotic indicated for the treatment of susceptible bacterial infections including acute sinusitis, acute exacerbations of chronic bronchitis, community acquired pneumonia, skin and skin structure, and complicated intra-abdominal infections. The bactericidal action results from inhibition of the topoisomerase II (DNA gyrase) and topoisomerase IV required for bacterial DNA replication, transcription, repair, and recombination.

RELATED: Infectious Disease Resource Center

Moxifloxacin is available in 400mg strength tablets in 30-count bottles.

For more information call (866) 733-3952 or visit DrReddys.com